A 3-year-old with persistent middle ear effusion for about 2 months after an acute otitis media episode has no fever or pain. What is the appropriate management?

A 3-year-old with persistent middle ear effusion for about 2 months after an acute otitis media episode has no fever or pain. What is the appropriate management?

• A. Start antibiotics now
• B. Tympanostomy tube placement
• C. Observation and follow-up
• D. Oral steroids

Answer: (C)

The main concept here is that after an acute otitis media, a child can have a persistent middle ear effusion without ongoing infection, and the best initial approach is watchful waiting. In a 3-year-old who is afebrile and without ear pain, the fluid in the middle ear often resolves on its own with time. Therefore, observation and follow-up to monitor for resolution of the effusion and to assess hearing and language development is appropriate. Antibiotics won’t help with a noninfectious effusion, and oral steroids haven’t shown benefit for otitis media with effusion. Tympanostomy tubes are considered only if the effusion persists longer (typically with associated hearing loss or speech concerns) or if there are recurrent infections, not at this early stage. So, the best management is to monitor and reassess rather than treat aggressively now.

The main concept here is that after an acute otitis media, a child can have a persistent middle ear effusion without ongoing infection, and the best initial approach is watchful waiting. In a 3-year-old who is afebrile and without ear pain, the fluid in the middle ear often resolves on its own with time. Therefore, observation and follow-up to monitor for resolution of the effusion and to assess hearing and language development is appropriate. Antibiotics won’t help with a noninfectious effusion, and oral steroids haven’t shown benefit for otitis media with effusion. Tympanostomy tubes are considered only if the effusion persists longer (typically with associated hearing loss or speech concerns) or if there are recurrent infections, not at this early stage. So, the best management is to monitor and reassess rather than treat aggressively now.